Campath 1H
Plasma Cell Neoplasm
Baylor College of MedicinePhase 1/2Dormant
D
30/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 15/ 100
- Competitive Position
- 95/ 100
Competitive context
21 Active assets in the Plasma Cell Neoplasm cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
cc-5013 Hellenic Society of Hematology | Phase 3 | BBB |
DEXAMETHASONE Hellenic Society of Hematology | Phase 3 | BBB |
Cyclophosphamide Affiliated Hospital to Academy of Military Medical Sciences | Phase 3 | BB |
Fludarabine Affiliated Hospital to Academy of Military Medical Sciences | Phase 3 | BB |
FILGRASTIM Hellenic Society of Hematology | Phase 3 | BB |
View all 49 →
Same molecule, other indications
Campath 1H is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →